Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-70
SponsorUniversity of Connecticut
About this trial
The major objective of this project is to examine whether daily consumption of milk polar lipids (MPLs) influences cardiometabolic risk factors.
Eligibility criteria
Qualifiers
LDL-C ≥ 130 mg/dL
Waist circumference ≥ 88 cm for women, ≥ 102 cm for men
Aged 18 to 70 years
Disqualifiers
Renal disease
Liver disease
Diabetes
Heart disease
Trial design
Treatments tested in this trial
- Milk Polar Lipid-Rich Dairy Powder
- Dairy Powder
Treatment groups
130 Participants
are divided into 2 treatment groupsLocations
1University of Connecticut06269, StorrsConnecticut, United States
Sponsors and collaborators
University of Connecticut
Lead sponsor
Dairy Management Inc.
Collaborator
Source ClinicalTrials.gov